X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1309) 1309
Newsletter (300) 300
Book Review (232) 232
Publication (116) 116
Conference Proceeding (17) 17
Magazine Article (10) 10
Newspaper Article (9) 9
Book Chapter (6) 6
Dissertation (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ranolazine (1573) 1573
index medicus (833) 833
humans (620) 620
cardiac & cardiovascular systems (456) 456
animals (373) 373
male (322) 322
piperazines - therapeutic use (283) 283
female (255) 255
angina pectoris (236) 236
pharmacology & pharmacy (229) 229
research (223) 223
piperazines - pharmacology (207) 207
acetanilides - therapeutic use (201) 201
atrial fibrillation (192) 192
care and treatment (173) 173
angina pectoris - drug therapy (171) 171
treatment outcome (167) 167
acetanilides - pharmacology (164) 164
ischemia (164) 164
analysis (163) 163
late sodium current (163) 163
drug therapy (157) 157
cardiovascular (148) 148
heart (148) 148
enzyme inhibitors - therapeutic use (139) 139
aged (138) 138
middle aged (136) 136
angina (133) 133
acetanilides (131) 131
abridged index medicus (117) 117
electrocardiography (117) 117
antianginal agent (113) 113
arrhythmia (107) 107
sodium channel blockers - pharmacology (106) 106
heart failure (104) 104
arrhythmias (103) 103
cardiac patients (101) 101
cardiology (100) 100
medical research (99) 99
piperazines - administration & dosage (99) 99
rats (97) 97
medicine, experimental (95) 95
reports (94) 94
atrial fibrillation - drug therapy (90) 90
cardiovascular agents - therapeutic use (89) 89
dose-response relationship, drug (84) 84
sodium channel blockers - therapeutic use (82) 82
action potentials - drug effects (81) 81
article (81) 81
myocytes, cardiac - drug effects (81) 81
anti-arrhythmia agents - pharmacology (79) 79
anti-arrhythmia drugs (78) 78
dosage and administration (78) 78
randomized controlled-trial (78) 78
diabetes (77) 77
disease models, animal (77) 77
acetanilides - administration & dosage (76) 76
anti-arrhythmia agents - therapeutic use (76) 76
drugs (76) 76
ranolazine - therapeutic use (76) 76
rabbits (75) 75
enzyme inhibitors - pharmacology (74) 74
piperazines - adverse effects (74) 74
exercise tolerance (72) 72
myocardial ischemia - drug therapy (72) 72
coronary heart disease (71) 71
pharmacology (71) 71
sodium - metabolism (70) 70
chronic stable angina (68) 68
chronic angina (67) 67
chronic disease (67) 67
amiodarone (66) 66
long-qt syndrome (66) 66
risk factors (66) 66
amlodipine (65) 65
atrial-fibrillation (64) 64
myocytes, cardiac - metabolism (64) 64
time factors (64) 64
inhibition (63) 63
peripheral vascular disease (63) 63
acetanilides - adverse effects (62) 62
atrial fibrillation - physiopathology (61) 61
coronary artery disease (61) 61
acute coronary syndromes (60) 60
electrophysiology (60) 60
cardiac arrhythmia (58) 58
internal medicine (58) 58
physiological aspects (58) 58
biological products industry (57) 57
cardiovascular disease (57) 57
clinical trials (57) 57
double-blind method (57) 57
heart rate - drug effects (57) 57
medicine & public health (57) 57
physiology (57) 57
repolarization (57) 57
calcium - metabolism (56) 56
drug therapy, combination (56) 56
heart-failure (56) 56
myocardial ischemia (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1561) 1561
German (24) 24
Spanish (22) 22
Italian (12) 12
Chinese (4) 4
French (4) 4
Polish (3) 3
Russian (3) 3
Japanese (2) 2
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 01/2013, Volume 73, Issue 1, p. 55
Journal Article
Neuroscience Letters, ISSN 0304-3940, 08/2012, Volume 524, Issue 2, p. 101
a* Threshold tracking can non-invasively provide data on axonal membrane properties. a* Increased persistent Na.sup.+ current (Na.sub.p) is related to... 
Ranolazine
Journal Article
Heart Rhythm, ISSN 1547-5271, 11/2009, Volume 6, Issue 11, p. 1625
Ranolazine is an antianginal drug that inhibits the cardiac late Na.sup.+ current (I.sub.Na). The selectivity of ranolazine to block late I.sub.Na relative to... 
Ranolazine
Journal Article
Biophysical Journal, ISSN 0006-3495, 01/2015, Volume 108, Issue 2, pp. 195a - 196a
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2004, Volume 43, Issue 5, pp. A128 - A128
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 07/2019, Volume 234, Issue 7, pp. 11587 - 11601
Cardiac hypertrophy and heart failure are characterized by increased late sodium current and abnormal Ca handling. Ranolazine, a selective inhibitor of the... 
Heart failure | ranolazine | transient | hypertrophy
Journal Article
Neuroscience Letters, ISSN 0304-3940, 06/2012, Volume 518, Issue 1, p. 36
a* Threshold tracking can non-invasively provide axonal membrane properties. a* Persistent Na.sup.+ current (Na.sub.p) is related to neurodegeneration and... 
Cyanides | Ranolazine
Journal Article
Journal of Pharmaceutical Sciences and Research, 02/2017, Volume 9, Issue 2, pp. 145 - 149
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 07/2016, Volume 26, Issue 13, pp. 3202 - 3206
Journal Article
Journal Article
Journal Article
Heart Rhythm, ISSN 1547-5271, 2015, Volume 12, Issue 5, pp. 872 - 878
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2016, Volume 18, Issue 5, pp. 463 - 474
To report the results of two phase III trials assessing the efficacy of ranolazine for glycaemic control in patients with type 2 diabetes on metformin or... 
clinical trial | antidiabetic drug | glycaemic control | type 2 diabetes | randomized trial | Type 2 diabetes | Clinical trial | Randomized trial | Antidiabetic drug | Glycaemic control | Ranolazine - adverse effects | Ranolazine - pharmacokinetics | Metformin - therapeutic use | Ranolazine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Metformin - adverse effects | Hypoglycemia - prevention & control | Glycated Hemoglobin A - antagonists & inhibitors | Hypoglycemic Agents - blood | Drug Therapy, Combination - adverse effects | Drug Interactions | Sodium Channel Blockers - adverse effects | Sodium Channel Blockers - therapeutic use | Female | Sulfonylurea Compounds - blood | Sulfonylurea Compounds - pharmacokinetics | Hypoglycemia - chemically induced | Drug Resistance | Metformin - blood | Hypoglycemic Agents - therapeutic use | Sodium Channel Blockers - blood | Hyperglycemia - prevention & control | Ranolazine - blood | Hypoglycemic Agents - pharmacokinetics | Double-Blind Method | Metformin - pharmacokinetics | Sulfonylurea Compounds - therapeutic use | Sulfonylurea Compounds - adverse effects | Diabetes Mellitus, Type 2 - blood | Aged | Cardiovascular Diseases - chemically induced | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Sodium Channel Blockers - pharmacokinetics | Hypoglycemic Agents - adverse effects | Glycosylated hemoglobin | Glimepiride | Care and treatment | Diabetes therapy | Confidence intervals | Diabetes | Clinical trials | Hemoglobin | Metformin | Diabetes mellitus | Index Medicus
Journal Article
by Zareba, Wojciech and Zareba, W and Daubert, James P and Daubert, J and Beck, C and Beck, Christopher A and Huang, David T and Huang, D and Alexis, Jeffrey D and Alexis, J and Brown, M and Brown, Mary W and Pyykkonen, Kathryn and Pyykkonen, K and McNitt, Scott and Oakes, D and Oakes, David and Feng, Changyong and Feng, C and Aktas, Mehmet K and Aktas, M and Ayala-Parades, Felix and Baranchuk, Adrian and Baranchuk, A and Dubuc, M and Dubuc, Marc and Haigney, Mark and Haigney, M and Mazur, Alexander and Mazur, A and McPherson, Craig A and McPherson, C and Mitchell, L.B and Mitchell, L. Brent and Natale, A and Natale, Andrea and Piccini, Jonathan P and Piccini, J and Raitt, Merritt and Raitt, M and Rashtian, Mayer Y and Rashtian, M and Schuger, Claudio and Schuger, C and Winters, Stephen and Winters, S and Worley, Seth J and Worley, S and Ziv, Ohad and Ziv, O and Moss, A.J and Moss, Arthur J and Moss, A and Buttaccio, A and Perkins, E and DeGrey, D and Robertson, S and Lansing, R and Oberer, A and Polonsky, B and Ross, V and Papernov, A and Schleede, S and McNitt S, S and Hall, W.J and Chen, L and Miller, A and Richeson, J.F and Rosero, S and Kutyifa, V and Shah, A and Lamas, G and Cohn, F and Harrell, F and Piña, I and Poole, J and Sullivan, M and Lathrop, D and Geller, N and Boineau, R and Trondell, J and Cooper, L and Itturiaga, E and Gottlieb, C and Greer, S and Perzanowski, C and Hedgepeth, C and Assal, C and Salam, T and Woollett, I and Tomassoni, G and Ayala-Paredes, F and Russo, A and Punnam, S and Sangrigoli, R and Sloan, S and Kutalek, S and Sun, A and Lustgarten, D and Monir, G and ...
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2018, Volume 72, Issue 6, pp. 636 - 645
Ventricular tachycardia (VT) and ventricular fibrillation (VF) remain a challenging problem in patients with implantable cardioverter-defibrillators (ICDs).... 
ventricular fibrillation | ranolazine | ventricular tachycardia | implantable cardioverter-defibrillator
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 11/2010, Volume 161, Issue 6, pp. 1414 - 1426
Journal Article
Revista Espanola de Cardiologia, ISSN 1885-5857, 01/2016, Volume 69, Issue 1, p. 45
Ranolazine is used as a complementary treatment for angina in symptomatic patients who are inadequately controlled with first-line antianginal therapies.... 
Ischemia | Ranolazine
Journal Article
Revista Espanola de Cardiologia, ISSN 0300-8932, 2016, Volume 69, Issue 1, pp. 45 - 53
Introduction and objectives Ranolazine is used as a complementary treatment for angina in symptomatic patients who are inadequately controlled with first-line... 
Ischemia-reperfusion | Cardioprotection | Ca2+ Ranolazine
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2016, Volume 37, Issue 19, pp. 1504 - 1513
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.